03/03/2021 7:55 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:48 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:47 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:43 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:42 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:39 PM | Huang Dennis Karl (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:38 PM | Dier Mardi (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:37 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:36 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 1:30 PM | Aliski William (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/16/2021 12:24 PM | Capital World Investors (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A
| |
02/16/2021 12:16 PM | Capital Research Global Investors (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A
| |
02/12/2021 12:06 PM | FEDERATED HERMES, INC. (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A
| |
02/03/2021 7:04 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/03/2021 7:03 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2021 7:02 PM | Aliski William (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2021 7:01 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/02/2021 3:28 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2021 7:30 AM | BlackRock Inc. (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A
| |
01/21/2021 7:46 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2021 3:01 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2021 6:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2021 6:05 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2021 8:16 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2021 5:45 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2020 3:15 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/10/2020 3:55 PM | Arcturus Therapeutics Holdings Inc. (Issuer) Ultragenyx Pharmaceutical (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2020 3:51 PM | Arcturus Therapeutics Holdings Inc. (Subject) Ultragenyx Pharmaceutical (Filed by)
| Form SC 13D/A
| |
12/07/2020 5:04 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2020 3:16 PM | Solid Biosciences Inc. (Subject) Ultragenyx Pharmaceutical (Filed by)
| Form SC 13D
| |
11/04/2020 2:44 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2020 4:05 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2020 3:05 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2020 4:28 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/30/2020 4:26 PM | Solid Biosciences Inc. (Issuer) Ultragenyx Pharmaceutical (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/29/2020 3:02 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5
| |
10/28/2020 6:52 AM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5
| |
10/27/2020 3:20 PM | Ultragenyx Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/27/2020 3:07 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/26/2020 3:11 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2020 7:16 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2020 6:23 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:22 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:21 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:20 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:20 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:19 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:18 PM | Huang Dennis Karl (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:16 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:15 PM | Sharp Shalini (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2020 4:55 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2020 4:53 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2020 4:52 PM | Dier Mardi (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2020 4:52 PM | Dier Mardi (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/13/2020 5:07 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2020 1:57 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2020 3:47 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/02/2020 3:26 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/02/2020 8:00 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2020 2:56 PM | Aliski William (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2020 1:12 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2020 1:11 PM | Sharp Shalini (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2020 11:21 AM | SIEGALL CLAY B (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2020 10:29 AM | Ultragenyx Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/15/2020 12:22 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2020 4:21 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2020 11:30 AM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2020 11:29 AM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2020 1:21 PM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2020 1:21 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 2:03 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2020 12:16 PM | Ultragenyx Pharmaceutical (Issuer) WELCH DANIEL G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 12:15 PM | SULIMAN SHEHNAAZ (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 12:14 PM | SIEGALL CLAY B (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 12:13 PM | NARACHI MICHAEL (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 12:12 PM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 12:11 PM | Ekman Lars (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 12:10 PM | Dunsire Deborah (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 12:10 PM | Aliski William (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2020 12:47 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2020 12:46 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2020 1:00 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2020 3:59 PM | Sharp Shalini (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2020 1:21 PM | Huang Dennis Karl (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2020 1:20 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2020 1:19 PM | Sharp Shalini (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2020 1:18 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2020 1:17 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/27/2020 2:14 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2020 4:21 PM | Arcturus Therapeutics Holdings Inc. (Subject) Ultragenyx Pharmaceutical (Filed by)
| Form SC 13D/A
| |
05/22/2020 12:41 PM | Arcturus Therapeutics Holdings Inc. (Issuer) Ultragenyx Pharmaceutical (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 6:50 PM | Aliski William (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 6:49 PM | Sharp Shalini (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2020 6:15 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2020 6:13 PM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2020 6:12 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2020 7:25 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2020 3:31 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2020 12:21 PM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A
| |
05/08/2020 7:12 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |